Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Rare Tumour Extracted From 36-year-old Patient at Manipal Hospitals Bangalore

Manipal Hospital Official Logo (PRNewsfoto/Manipal Health Enterprises Priv)

News provided by

Manipal Hospitals Bangalore

19 Feb, 2020, 14:46 IST

Share this article

Share toX

Share this article

Share toX

- Multi-disciplinary approach saved life of 36-year-old patient with Spinal Paraganglioma tumor

- Ten Hours, Five Doctors, One Life Saved at Manipal Hospitals Bangalore

BANGALORE, Feb. 19, 2020 /PRNewswire/ -- Manipal Hospitals Bangalore achieved yet another medical marvel by successfully removing a rare tumor of the nerve cells, 'Paraganglioma' which was secreting excess hormone and was present at the lower back, near the spine of 36-year-old patient Mr. Jagadeesh Ratha. A multidisciplinary team with specialized doctors from different streams got together to perform this complex surgery: Dr. Praveen M Ganigi, Consultant, Neurosurgery, Dr. Bopanna KM, Consultant, Neurosurgery, Dr. Shabber Zaveri, Consultant, Cancer Care and Dr. Karthik Prabhakar, Consultant, Diabetes & Endocrinology, Dr. G S Nagaraja Prabhakar, Consultant, Anesthesiology.

Continue Reading
(L- R)  Dr. Karthik Prabhakar, Consultant, Diabetes & Endocrinology,   Manipal Hospitals Bangalore, Mr. Jagadeesh Ratha (patient), Dr. Praveen M Ganigi, Consultant, Neurosurgery,  Manipal Hospitals and Dr. G S Nagaraja Prabhakar, Consultant, Anesthesiology, Manipal Hospitals Bangalore Bangalore sharing details on this rare tumor and the challenging surgery.
(L- R) Dr. Karthik Prabhakar, Consultant, Diabetes & Endocrinology, Manipal Hospitals Bangalore, Mr. Jagadeesh Ratha (patient), Dr. Praveen M Ganigi, Consultant, Neurosurgery, Manipal Hospitals and Dr. G S Nagaraja Prabhakar, Consultant, Anesthesiology, Manipal Hospitals Bangalore Bangalore sharing details on this rare tumor and the challenging surgery.

Mr. Jagadeesh Ratha, was on medication for Hypertension since many years. He was facing recurrent lower backache for the past one year with radiating right lower limb pain since 8 months. He also reported to have lost weight over the past 6 months. Thorough investigation revealed that he was suffering from a spinal paraganglioma, with excess secretion of Catecholamine hormone leading to hypertension.

Dr. Karthik Prabhakar, Consultant, Diabetes & Endocrinology, Manipal Hospitals Bangalore said, "According to a recent study, these kind of tumors are found in 2 out of every million people each year and are the cause of high blood pressure in less than 0.2% of people. Though in this case, it was a benign tumor, but excess release of catecholamine from the tumor in uncontrolled bursts could cause serious health problems like stroke, heart attacks and even death to the patient. Therefore, he required a multi-disciplinary attention."

Speaking about the case, Dr. Praveen M Ganigi, Consultant, Neurosurgery, Manipal Hospitals Bangalore, said, "Spinal Paraganglioma is rare, with approximately 90 cases reported in the literature and can affect people between the ages of 30 and 50. The surgery was conducted in two steps, one from the front and another one from the back of the spine, taking a total of around 10 hours of complex surgery with constant monitoring of his vital sings".

Dr. G S Nagaraja Prabhakar, Consultant, Anesthesiology, Manipal Hospitals Bangalore said, "Since the urinary metanephrines' value was on the higher side, we had to initiate adrenergic receptor blockers, along with appropriate antihypertensive medications for preoperative BP management. During surgery, hormones in the tumor could be released and could cause serious problems such as elevated blood pressure and pulse. We had to be alert and maintain his body stable at the time of the surgery."

"For these kind of rare cases of paraganglioma, complete removal of tumour by surgical resection is the first choice of treatment with or without radiotherapy. However, since paragangliomas are highly vascular lesions and in view of anticipated large volume blood loss, Jagadeesh underwent pre-operative endovascular embolization to cut off blood supply to the tumor," added Dr. Shabber Zaveri, Consultant, Cancer Care, Manipal Hospitals Bangalore.

As it was a spinal paraganglioma, it could also change the shape of the spinal cord, which could have been disastrous. Therefore, the doctors had to reconstruct the spine as well, post removing the tumor.

Dr. Bopanna KM, Consultant, Neurosurgery, Manipal Hospital Bangalore, said, "Post-surgery and upon review he was evaluated and was symptomatically better, mobilizing independently and healing well with no fresh deficits. The patient underwent regular physiotherapy and was mobilized with thoraces-lumbar brace post the surgery as per the physical rehabilitation team and was discharged in a stable condition."

Expressing his happiness on the treatment, Mr. Jagadeesh Ratha, said, "I have recovered completely and now leading a happy and normal life all thanks to the team of doctors at Manipal Hospitals. This was a true example of success achieved via teamwork. All the doctors were extremely supportive throughout the procedure and gave me the confidence to recover. I appreciate the efforts and commitment of the doctors."

About Manipal Hospitals:

As a pioneer in healthcare, Manipal Hospitals is among the largest hospital network in India serving over 2 million patients annually. Its focus is to develop an affordable tertiary care multispecialty healthcare framework through its entire multispecialty delivery spectrum and further extend it to homecare. With its flagship quaternary care facility located in Bangalore, India, 7 tertiary care, 5 secondary care, and 2 primary care clinics spread across India and abroad, today Manipal Hospitals successfully operates and manages 5,900 beds across 15 hospitals. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from across the globe. Manipal Hospitals has one-day care clinic in Lagos, Nigeria. Manipal Hospitals is first in India to be awarded accreditation by the AAHRPP for ethical standards in clinical research activities. It is also NABL, NABH and ISO certified. Manipal Hospitals is also the most respected hospital company in India and the most patient recommended hospital in India by consumer survey.

Media Contact:
Bhavana B
[email protected]
+91-9845348652
AGM
Manipal Hospital Bangalore

Photo: https://mma.prnewswire.com/media/1092309/Manipal_Hospitals_Doctors_Paraganglioma.jpg
Logo: https://mma.prnewswire.com/media/1030636/Manipal_Hospitals_Logo.jpg

Modal title

Also from this source

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

For many youngsters, cancer remains an abstract and frightening concept that would mean – the end of life. This public health concern is often...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.